Free tool
Diagnostics stocks
We cover 6 companies grouped under the Diagnostics theme. The median market value in the group is $13.65B. Across the group, the median move over the past trading day is +0.36%. Price change over the past year runs from −41.8% to +166.6% across the middle 80 percent of the group, with a median of +29.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
6 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.